Ceribell with Clarity offers 24/7 bedside EEG monitoring and alerts

At the bedside, Clarity provides:

First FDA-cleared instantaneous bedside alert indicating suspected status epilepticus

Continuous EEG monitoring and seizure burden display*

Remotely, Clarity provides:

First FDA-cleared seizure burden trend for effective patient management

The most accurate EEG seizure burden labeling

Real-time medication effectiveness

Easily annotate medications at the bedside with just a touch

Intuitive medication response for treatment optimization in real-time

Clinical Impact

Provides consistently high performance that minimizes inter-rater variability⁵³

100%

sensitivity in detecting and alerting for status epilepticus

88%

sensitivity for identifying epileptiform activity

99%

accuracy in ruling out seizure and seizure-like activity

Economic Impact

Enhances your EEG capability to 24/7 on-site monitoring while realizing significant savings

Minimize delays in treating non-convulsive status epilepticus
Avoid unnecessary anti-epileptic drug treatment
Avoid unnecessary patient transfers
Reduce patients length of stay

*Seizure burden is the prevalence defined by the American Clinical Neurophysiology Society (ACNS) as the percentage of time that EEG shows seizure activity.
American Clinical Neurophysiology Society’s Standardized Critical Care EEG Terminology: 2012 version. Journal of Clinical Neurophysiology, Volume 30, Number 1, February 2013